ThromboGenics Struggles to Find Patients for Phase II Eye Disease Trial Post author:Sam Post published:December 7, 2017 Post category:BioPharma Resources redirected to progress new drug candidates to clinic in H1 2018. Source: BioSpace You Might Also Like AstraZeneca PLC Dumps Two Drugs From Pipeline, Causing an Ex-Partner's Stock to Tank Some More April 26, 2017 InspireMD Announces Distribution Agreement For CGuard EPS In Taiwan June 7, 2017 uniQure Researchers Swap Out Lead Drug for a Better Prospect October 18, 2017
AstraZeneca PLC Dumps Two Drugs From Pipeline, Causing an Ex-Partner's Stock to Tank Some More April 26, 2017
